Floatz logo

Polypepi1018

Metastatic Microsatellite Stable Colorectal Carcinoma

Mayo ClinicPhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

160 Active assets in the Metastatic Microsatellite Stable Colorectal Carcinoma cohort.

Asset / SponsorPhaseRating
TIPIRACIL
Mayo Clinic
Phase 2BBB
FLUOROURACILUM
City of Hope Medical Center
Phase 4BB
Eloxatin
First Affiliated Hospital of Zhejiang University
Phase 4BB
MITOMYCIN C
City of Hope Medical Center
Phase 3BB
Capecitabine
First Affiliated Hospital of Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

Polypepi1018 is also rated in:

colorectal cancerDormant
CCC
Indicative ·
52 / 100
View asset →
metastatic malignant neoplasm in the colonDormant
CCC
Indicative ·
48 / 100
View asset →
colorectal cancerDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →